Peralta A, Lazcano Á, Reyes Y, Redondo F, Marti J, Ríos N, Guerrero AG

Language: Spanish
References: 12
Page: 247-251
PDF size: 283.74 Kb.

ABSTRACT

Introduction: In Mexico the incidence of breast cancer only looks overcome by the cervicouterine cancer, the mean age of women that suffer it is between the 40 and 54 years old. Breast cancer is an example of not preventable pathology and where the only way of decreasing mortality is through its early detection, adequate and opportune handling, so that the mammography at present pacienconstitutes the best available proof for the detection and opportune diagnosis of breast cancer.
Materials and methods: A retrospective study at the Hospital General de México which files of patients who attended from January 1 to December 31, 2007 at the Mastography service for carrying out a screening mastography, were reviewed. 51 patients with a mean age were selected between the 33 and 78 years old.
Results: The most common incidence of palpable lesions found in the age group of 49 to 50 years (69.2%). The more frequent not palpable lesions were nodules associated to micro-calcifications (38.4%), followed by the micro-calcifications and nodules (19.2%).
Conclusions: Mastography is the selection method for the identification of breast cancer in asymptomatic patients, besides being the selection exam in the mammary screening, due to its high sensitivity (70-90%).

REFERENCES

1. Rodríguez-Cuevas SA, Capurro-García M. Epidemiología del cáncer de mama. Ginecol Obstet Mex 2006; 74: 585-93.

2. Hernández CNI, Sandoval GF, Hernández GM. Lesiones de mama no palpables sospechosas de malignidad. Correlación radiológica quirúrgica (Hospital General de México, O.D). Gamo 2007; 6(2): 42-6.

3. Brandan ME, Villaseñor NY. Detección de cáncer de mama. Estado de la mamografía en México. Cancerología 2006: 1: 147-62.

4. INEGI. Anuario Estadístico de los Estados Unidos Mexicanos, eds. 1999- 2005. http://www.inegi.gob.mx/prod_serv/contenidos/espanol/biblioteca/default.asp?c=694.

5. Taveras JM, Ferrucci JT. Radiology Diagnosis Imagining intervention. Vol. 1 Cap. 89. Philadelphia: Lippincott; 1994.

6. Kopans BD, Mendelsen BE. Syllabus: A categorical Course in breast imagining. RSNA Publications; 1995 p. 150-9.

7. Svane G, et al. Screening Mammography: Breast Cancer Diagnosis in Asyntomatic Women. St. Louis, Missouri: Mosby; 1993. p. 477.

8. Shaw de Paredes E. Evaluation of Abnormal Screening Mammograms. Cáncer 1994; 74: 342-9.

9. Hincapie UAL, Patiño PJH, Quiceño CW. Correlación Mamográfica e histológica de lesiones mamarias no palpables biopsia por estereotaxia. Medellín 1995-1996.

10. Camacho J, Barriga C, Osorio S, Lobo M. Lesiones no palpables de mama: resultado de biopsia radioquirúrgica. Rev Chilena de Cirugía 2002; 54(2): 139-42.

11. Castellanos AR, Aceves GI, Santillán RJH, Vázquez ZVM, Idhaly LC, Palacios MR. Lesiones mamarias no palpables: biopsia mediante marcaje con arpón. Gacerta Mexicana de Oncología 2006; 5(2): 40-3.

12. Winchester DJ. American Cáncer Society. Cancer de mama. Atlas de oncología médica. España: Elsevier; 2001, p. 41.